Literature DB >> 3178527

Intracranial operation within seven days of aneurysmal subarachnoid hemorrhage. Results in 150 patients.

H P Adams1, N F Kassell, G A Kongable, J C Torner.   

Abstract

We evaluated the results of intracranial operation in 150 consecutive patients surgically treated within seven calendar days of aneurysmal subarachnoid hemorrhage (SAH). Patients in all clinical grades, except those who were moribund, were treated. Those with either anterior or posterior circulation aneurysms were included. On follow-up assessment, favorable outcomes were noted in 107 patients (71%), 17 had major disabilities (11%), and 26 had died (17%). During hospitalization, vasospasm was diagnosed in 63 patients (42%) and rebleeding occurred in 39 (25%). Operations were performed throughout the first week after SAH; results of operation were similar on each day. A lower rate of good recovery was observed among patients operatively treated four to seven days after SAH than among those operated on earlier. The admitting neurologic condition influenced outcome after early operation, but age did not have a major impact. We find that aneurysm surgery can be performed within one week of SAH with acceptable results, although there is room for improvement.

Entities:  

Mesh:

Year:  1988        PMID: 3178527     DOI: 10.1001/archneur.1988.00520340019004

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

Review 1.  Changing practices in neuroanaesthesia.

Authors:  J C Drummond
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

2.  Management of the ruptured intracranial aneurysm--early surgery, late surgery, or modulated surgery? Personal experience based upon 468 patients admitted in two periods (1972-1984 and 1985-1989).

Authors:  R Deruty; C Mottolese; I Pelissou-Guyotat; J F Soustiel
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

3.  Aneurysmal bleeding. A plea for early surgery in good-risk patients.

Authors:  R T Thomeer; J C Taal; J H Voormolen; A R Wintzen
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.